Shanghai Iaso Biotechnology Co., Ltd
Clinical trials sponsored by Shanghai Iaso Biotechnology Co., Ltd, explained in plain language.
-
New lupus drug candidate enters human safety testing
Disease control Recruiting nowThis early-stage study tests a new drug called IASO-782 in 20 adults with systemic lupus erythematosus (SLE). The main goal is to see if the drug is safe and tolerable. Participants will receive either the drug or a placebo, and researchers will monitor for side effects.
Phase: PHASE1 • Sponsor: Shanghai IASO Biotechnology Co., Ltd • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New drug IASO-782 aims to tame immune attacks on blood cells
Disease control Recruiting nowThis early-stage trial is testing a new drug called IASO-782 in 16 adults with autoimmune thrombocytopenia (ITP) or warm autoimmune hemolytic anemia (wAIHA). These conditions cause the immune system to mistakenly attack blood cells. The study's main goal is to check the drug's sa…
Phase: PHASE1 • Sponsor: Shanghai IASO Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC